Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension

Combination therapy adding tadalafil to existing ambrisentan in patients with pulmonary arterial hypertension

(2014) Akihiro Hirashiki et al.   HYPERTENSION RESEARCH

Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension

(2014) Yugang Zhuang et al.   HYPERTENSION RESEARCH

Double-Blind, Placebo-Controlled Clinical Trial With a Rho-Kinase Inhibitor in Pulmonary Arterial Hypertension

(2013) Yoshihiro Fukumoto et al.   CIRCULATION JOURNAL

Inhibition of the Ca2+-sensing receptor rescues pulmonary hypertension in rats and mice

(2013) Qiang Guo et al.   HYPERTENSION RESEARCH

Definitions and Diagnosis of Pulmonary Hypertension

(2013) Marius M. Hoeper et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pulmonary Hypertension in the Intensive Care Unit

(2012) Hooman D. Poor et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Survival of Chinese Patients With Pulmonary Arterial Hypertension in the Modern Treatment Era

(2011) Rui Zhang et al.   CHEST

Characteristics and Outcome After Hospitalization for Acute Right Heart Failure in Patients With Pulmonary Arterial Hypertension

(2011) François Haddad et al.   Circulation-Heart Failure

Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension

(2011) A. Campo et al.   EUROPEAN RESPIRATORY JOURNAL

Riociguat for the treatment of pulmonary hypertension

(2011) Ralph T Schermuly et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Vasoactive Drugs in Circulatory Shock

(2010) Steven M. Hollenberg   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension

(2010) Hiroshi Fujita et al.   HEART AND VESSELS

Evidence for Rho-Kinase Activation in Patients With Pulmonary Arterial Hypertension

(2009) Zhulanqiqige Do.e et al.   CIRCULATION JOURNAL

Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem

(2009) Jeremy PT Ward et al.   CURRENT OPINION IN PHARMACOLOGY

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension

(2009) B. Sztrymf et al.   EUROPEAN RESPIRATORY JOURNAL

Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension

(2009) Robyn J. Barst et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Acute Inhibition of Rho-Kinase Attenuates Pulmonary Hypertension in Patients with Congenital Heart Disease

(2008) Fuhai Li et al.   PEDIATRIC CARDIOLOGY